Vitrolife AB (FRA:VTFN) FCF Margin % : 19.02% (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vitrolife AB's Free Cash Flow for the three months ended in Mar. 2024 was €14.1 Mil. Vitrolife AB's Revenue for the three months ended in Mar. 2024 was €74.3 Mil. Therefore, Vitrolife AB's FCF Margin % for the quarter that ended in Mar. 2024 was 19.02%.

As of today, Vitrolife AB's current FCF Yield % is 2.98%.

The historical rank and industry rank for Vitrolife AB's FCF Margin % or its related term are showing as below:

FRA:VTFN' s FCF Margin % Range Over the Past 10 Years
Min: 14.71 Med: 20.81 Max: 28.84
Current: 21.55

During the past 13 years, the highest FCF Margin % of Vitrolife AB was 28.84%. The lowest was 14.71%. And the median was 20.81%.

FRA:VTFN's FCF Margin % is ranked better than
93.63% of 832 companies
in the Medical Devices & Instruments industry
Industry Median: -7.38 vs FRA:VTFN: 21.55

Vitrolife AB FCF Margin % Historical Data

The historical data trend for Vitrolife AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB FCF Margin % Chart

Vitrolife AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

22.04

27.00

19.10

16.98

18.17

Vitrolife AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															16.74	23.31	25.24	18.90	19.02

Competitive Comparison of Vitrolife AB's FCF Margin %

For the Medical Devices subindustry, Vitrolife AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vitrolife AB's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's FCF Margin % falls into.

Vitrolife AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vitrolife AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	57.036	/	313.963
	=	18.17 %

Vitrolife AB's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	14.138	/	74.315
	=	19.02 %

Vitrolife AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vitrolife AB (FRA:VTFN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (FRA:VTFN) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

VITR:Sweden 0YAY:UK

Address

Box 9080, Gothenburg, SWE, 400 92

Website

https://www.vitrolife.com

Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (FRA:VTFN) Headlines

No Headlines